Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms- |
Target- |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC10H14FN3O |
InChIKeyWESWLMZJUVKINK-KXMUYVCJSA-N |
CAS Registry2236564-04-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | - | - |